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The reproducibility of late gadolinium
enhancement cardiovascular magnetic
resonance imaging of post-ablation atrial
scar: a cross-over study
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James Harrison1,3, Constantine Butakoff2, Oscar Camara2, Amedeo Chiribiri1,3, Tobias Schaeffter1,
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Abstract
Background: Cardiovascular magnetic resonance (CMR) imaging has been used to visualise post-ablation atrial scar
(PAAS), generally employing a three-dimensional (3D) late gadolinium enhancement (LGE) technique. However the
reproducibility of PAAS imaging has not been determined. This cross-over study is the first to investigate the
reproducibility of the technique, crucial for both future research design and clinical implementation.
Methods: Forty subjects undergoing first time ablation for atrial fibrillation (AF) had detailed CMR assessment of PAAS.
Following baseline pre-ablation scan, two scans (separated by 48 h) were performed at three months post-ablation. Each
scan session included 3D LGE acquisition at 10, 20 and 30 min post administration of gadolinium-based contrast agent
(GBCA). Subjects were allocated at second scan post-ablation to identical imaging parameters (‘Repro’, n = 10), 3 T scanner
(‘3 T’, n = 10), half-slice thickness (‘Half-slice’, n = 10) or half GBCA dose (‘Half-gad’, n = 10). PAAS was compared to baseline
scar and then reproducibility was assessed for two measures of thresholded scar (% left atrial (LA) occupied by PAAS
(%LA PAAS) and Pulmonary Vein Encirclement (PVE)), and then four measures of non-thresholded scar (point-by-point
assessment of PAAS, four normalisation methods). Thresholded measures of PAAS were evaluated against procedural
outcome (AF recurrence).
Results: A total of 271 3D acquisitions (out of maximum 280, 96.7%) were acquired. At 20 and 30 min, inter-scan
reproducibility was good to excellent (coefficient of variation at 20 min and 30 min: %LA PAAS 0.41 and 0.20; PVE 0.13
and 0.04 respectively for ‘Repro’ group). Changes in imaging parameters, especially reduced GBCA dose, reduced inter-
scan reproducibility, but for most measures remained good to excellent (ICC for %LA PAAS 0.454–0.825, PVE 0.618–0.809
at 30 min). For non-thresholded scar, highest reproducibility was observed using blood pool z-score normalisation
technique: inter-scan ICC 0.759 (absolute agreement, ‘Repro’ group). There was no significant relationship between indices
of PAAS and AF recurrence.
Conclusion: PAAS imaging is a reproducible finding. Imaging should be performed at least 20 min post-GBCA injection,
and a blood pool z-score should be considered for normalisation of signal intensities. The clinical implications of these
findings remain to be established in the absence of a simple correlation with arrhythmia outcome.
Trial registration: United Kingdom National Research Ethics Service 08/H0802/68 – 30th September 2008.
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Background
The technique of three dimensional (3D) late gadolinium
enhanced (LGE) cardiovascular magnetic resonance
(CMR) imaging for the assessment of post-ablation atrial
scar (PAAS) has been used for almost a decade [1, 2]
but its reproducibility has never been formally quanti-
fied. An assessment of reproducibility is crucial from
both a clinical and research perspective as the use of the
technique becomes increasingly mainstream [3–8]. From
a clinical perspective, confidence in the technique should
be founded upon the knowledge that the location of
PAAS remains fixed between scanning sessions. At a re-
search level, the reproducibility of an imaging technique
has a profound impact upon the design and scaling of
research studies [9] and the interpretation of its results.
This study aimed to quantify the reproducibility of im-
aging of PAAS, between multiple acquisitions, scanning
sessions and established variations in imaging protocols.
There is no single established metric of PAAS imaging
for comparison in assessment of reproducibility. Whilst
some have looked to determine scar burden and location
[7, 10, 11], others have sought to determine the presence
of gaps in the ablation line [5, 6], each using bespoke
thresholding and image interrogation techniques. There-
fore, methods were developed specifically for this study in
order to describe quantitative measures of PAAS imaging
for reproducibility assessment: global PAAS burden
(proportion of the left atrium (LA) occupied by PAAS, %
LA PAAS), pulmonary vein encirclement (PVE- an object-
ive method of quantification of ablation gaps), and a new
method for point-by-point assessment of scar location .
Furthermore, recent studies of PAAS have tended to
use very different scanning parameters. These variations
include differing slice thickness (2–2.5 mm [3–5, 10] to
4 mm [6–8]), different gadolinium based contrast agents
(GBCAs) and doses (varying from 0.1–0.4 mmol/kg of
Multihance [10], Magnevist [7, 8], or Gadovist [5, 6]),
and different scanner bore strengths (1.5 T [4, 6–8, 10],
3 T [5], or both [3]). Therefore, in assessment of
reproducibility it was necessary to investigate the impact
of these variations in detection and designation of PAAS.
This cross-over study sought to determine the repro-
ducibility of PAAS imaging within and across scanning
techniques.
Methods
Study population
Between January 2014 and January 2016, all patients
undergoing routine CMR imaging (Scan 0) prior to first-
time atrial fibrillation (AF) ablation procedure were
approached for participation. Forty subjects provided
written and informed consent and the study was
approved by the National Research Ethics Service (South
London Research Ethics Committee reference 08/
H0802/68). Exclusion criteria were contraindication to
CMR imaging or prior allergic reaction to GBCA con-
trast. Baseline demographics and comorbidities were
documented at the initial scan.
All patients underwent further CMR imaging on two
occasions following clinically indicated catheter ablation
for AF (Fig. 1) The first post-ablation CMR scan (Scan
1) was performed at approximately three months after
the ablation procedure, regardless of rhythm or
arrhythmia recurrence (median 94 days, (interquartile
range (IQR) 89–101 days)), and was performed using
standard acquisition parameters (see below). A second
scan session (Scan 2) was performed 2 days later (me-
dian 48.1 h, IQR 47.9–49.1 h). Subjects were allocated to
scan 2 in 3 T scanner or the same 1.5 T scanner. 3 T
scanner availability was limited, precluding randomisa-
tion of allocation, but the allocation (n = 10) was per-
formed without reference to patient outcome or
demographics. The remaining patients were randomised
in equal ratios to one of three different imaging param-
eter groups for scan 2: repeat scan with identical acquisi-
tion parameters (‘Repro’ group, n = 10), repeat with half
dose of GBCA (‘Half-gad’ group, n = 10), or repeat with
half-slice thickness (‘Half-slice’ group, n = 10).
CMR protocol
All CMR imaging was performed on a 1.5 T MR-
scanner (Ingenia, Philips Healthcare, Best, Netherlands),
except for those allocated to 3 T scanner for scan 2. All
patients underwent detailed assessment at pre-
procedural CMR scan (Scan 0), including left ventricular
(LV) and right ventricular (RV) volumes and function,
LA volumes and function, and 3D LGE assessment of
baseline LA fibrosis. Details of the methods used to
quantify baseline LA fibrosis are available in the online
supplement. Cine imaging was performed in an end-
expiration breathhold using a standard multislice bal-
anced steady state free precession (bSSFP) technique (ef-
fective TR 2.7 msec, TE 1.3 msec, 1.4 × 1.4mm2 in-plane,
slice thickness 10 mm, 50 phases). 3D inversion recovery
spoiled gradient echo (LGE) acquisition was performed
with coverage to include the whole of the LA in axial
orientation. (TR 5.5 msec, TE 3.0 msec, flip angle 25°,
low-high k-space ordering, respiratory and electrocardio-
gram (ECG)-triggering (end atrial diastole, maximum
120 msec acquisition window, respiratory navigator lead-
ing with gating window 5 mm), 1.3 × 1.3x4mm3 (typic-
ally 50 slices per acquisition, reconstructed to 0.94 ×
0.94x2mm3), SPIR fat suppression, pixel bandwidth
540 Hz, phase-encoding direction anterior-posterior
(AP), parallel imaging: SENSE P-reduction (AP) factor 2,
32 channel phased array digital receiver coil). Average
acquisition window onset was 296 ± 40 msec post R-
wave, and end at 398 ± 39 msec. GBCA dose for
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standard acquisition was 0.2 mmol/kg Gadovist (Bayer
HealthCare Pharmaceuticals, Berlin, Germany). Respira-
tory gating artefact was minimised using an obtuse
angulation of the navigator at the extreme right poster-
ior aspect of the diaphragm, minimising excitation of
pulmonary venous blood flow.
Scan 1 (post-procedure) was performed using the same
3D LGE acquisition parameters as the baseline scan, and
a total of three LA 3D LGE datasets were acquired,
timed to start at 10 min, 20 min and 30 min after GBCA
administration. The inversion time was determined from
a Look-Locker acquisition performed immediately prior
to each LGE acquisition to ensure nulling of the myocar-
dium. In rare cases in which the acquisitions took longer
than 10 min, the subsequent acquisition was started
immediately.
Scan 2 (post-procedure) was performed with specific
modifications of the baseline scan, with acquisitions
again performed at 10 min, 20 min and 30 min post
GBCA administration.
1. Reproducibility (‘Repro’): n = 10, identical
parameters to Scan 1.
2. Half-gadolinium dose (‘Half-gad’): n = 10,
0.1 mmol/kg of Gadovist
3. Half-slice thickness (‘Half-slice’): n = 10, the
acquired voxel size was reduced to 1.3 × 1.3x2mm3
(reconstructed 0.625 × 0.625x1mm). Field of view
remained unchanged to cover the entire LA, and
therefore approximately 90–100 slices were
acquired, doubling the nominal acquisition duration.
4. 3 T scanner (‘3 T’): n = 10, scans were performed
on 3 T scanner (Achieva, Philips Healthcare) with
32-channel coil. Parameters were matched to those
for 1.5 T scanning as closely as possible (TR
4.0 msec, TE 2.0 msec, slice thickness 4 mm, pixel
bandwidth 620 Hz, acquired voxel size 1.3 ×
1.3x4mm3).
An ECG-triggered magnetic resonance angiogram
(MRA) 3D dataset was also acquired at each scan as a
high contrast template, delineating the LA endocardial
border. The acquisition was commenced 90s after the
start of a slow infusion of GBCA at 0.3 ml/s [12] (see
online supplement for details), with the same coverage
as the subsequent LGE acquisitions.
Fig. 1 Flowchart demonstrating subject allocation and number of scan acquisitions achieved
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Atrial fibrillation ablation protocol
Two experienced operators performed all catheter abla-
tion procedures under general anaesthesia using Carto3
(Biosense Webster/Johnson&Johnson, Irvine, California,
USA) electroanatomic mapping system, with the excep-
tion of 8 procedures performed using EnSite Velocity (St
Jude Medical, St. Paul, Minnesota, USA). For patients with
a diagnosis of paroxysmal AF and in sinus rhythm, a
point-by-point wide area circumferential ablation
(WACA) achieving pulmonary vein isolation (PVI) was
performed using 8Fr irrigated SmartTouch catheter (Bio-
sense Webster), or 8Fr irrigated TactiCath catheter (St
Jude Medical). Target ablation parameters were > 5 g for
at least 15 s per radiofrequency (RF) delivery location.
Power was 30 W throughout except on the posterior wall,
where it was limited to 25 W. Procedural endpoint was
defined as PV isolation as confirmed on entry block (and
exit block if capture achieved). For patients presenting
with persistent AF, a WACA was performed followed by
additional ablation lesion sets (mitral line, roof line,
inferior posterior line, complex fractionated electrogram
ablation) as a step-wise ablation.
Imaging interrogation and comparison technique
For all subjects a semi-automated segmentation of the
LA within the ECG-gated MRA acquisition was per-
formed. The segmentation was then automatically regis-
tered (rigid registration with six degrees of freedom (3
translations and 3 rotations) [13]) independently to each
LGE acquisition of the same imaging session (Acq1,
Acq2, Acq3, see Table 1 for nomenclature). Mean trans-
lation was of magnitude 1.9 ± 1.6 mm, and rotation 0.62
± 0.41°. For the subsequent imaging session at 48–72 h,
the MRA acquisition at post-ablation scan 1 (MRA1)
was automatically registered to the GMRA acquisition of
post-ablation scan 2 (MRA2), which was itself then regis-
tered to each subsequent LGE acquisition (Acq4, Acq5,
Acq6). Through this method, an identical atrial shell
could be used for all six acquisitions for most subjects.
The MRA was inadequate for semi-automated segmen-
tation, according to visual assessment of poor contrast-
to-noise ratio (CNR), in five subjects, for whom a man-
ual segmentation of Acq1 was performed, and registered
to all subsequent acquisitions.
The CMR LGE volume was interrogated using a
maximum intensity projection (MIP) technique, 1 mm
inside endocardial shell and 3 mm beyond endocar-
dial shell, and a single signal intensity (SI) value was
assigned to each triangular face of the newly gener-
ated .vtk shell (typically 40,000 faces per LA shell).
Comparison between two acquisitions i and j is
termed Ci,j (see Table 1). Where only one subgroup
was assessed, the comparisons are termed Ci,j[repro],
Ci,j[half-gad], Ci,j[half-slice] and Ci,j[3 T] respectively.
Multiway comparisons between acquisitions i, j,... j + 1
are termed Ci,j…,j + 1.
Reproducibility of thresholded scar
Research groups have almost universally chosen to thresh-
old PAAS, and a variety of normalisation methods and ab-
solute thresholds have been implemented [4–8, 10, 14].
However, evidence for identification of thresholds has fre-
quently relied upon correlation with voltage mapping
techniques [14, 15], which are prone to registration and
voltage sampling errors, or extrapolation from ventricular
scar studies [16]. A histologically validated value of 3.3
standard deviations (SD) above the blood pool mean was
therefore used for all indices where a single threshold
value was required [17].
Comparison of pre- and post-ablation atrial scar
In order to assess the impact of pre-ablation scar, a base-
line analysis was performed to compare locations of scar
on Acq0 (pre-ablation) to each of the post-ablation ac-
quisitions. In contrast to the baseline fibrosis assess-
ment, which was performed using a threshold of 0.97×
blood pool SI on a mean intensity projection [15] (see
Additional file 1), for this assessment Acq0 was instead
thresholded at the post-ablation scar threshold of 3.3SD
above blood pool mean on maximum intensity projec-
tion. Total proportion of the surface area of the Acq0
LA shell occupied by scar that would achieve the thresh-
old for PAAS was assessed and compared to each post-
ablation shell. A Sørensen Dice Similarity Coefficient
(DSC) [18] was then calculated, assessing the co-
location of pre- and post-ablation scar on a point-by-
point basis (C0,1 to C0,6) (Eq. 1).
DSC0; j ¼
2 Scar0∩Scar j
 
All Scar0 þ All Scar j ð1Þ
where DSC0,j is the DSC for the comparison of Acq0
with Acqj, both thresholded at 3.3SD above the blood
pool mean for the identification of scar.
To enable comparison where there was a change in
LA shape or size following ablation, the pre-ablation
shell was fused to the post-ablation shell using an itera-
tive closest point method, blinded to scar location [8].
Reproducibility of post-ablation thresholded scar
Two measures of thresholded PAAS were assessed. The
first measure was that of the proportion of the surface
area of the LA shell occupied by PAAS (%LA PAAS).
The second measure of PAAS was an objective measure
of PVE by PAAS (a gap quantification method). In brief,
the technique aimed to perform an objective measure-
ment of the proportion of the WACA line that is occupied
by uninterrupted scar on LGE CMR (Fig. 2) and the
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details of the derivation of PVE are documented in the on-
line supplement.
Reproducibility of scar imaging without thresholding
These two measures (%LA PAAS and PVE) are both
highly dependent upon the scar threshold, and therefore
the imaging reproducibility was also assessed point-by-
point using a method that was not dependent upon
thresholding. However, SI is expressed in arbitrary units,
and therefore normalisation methods were required to
enable inter-acquisition comparisons.
Signal intensity normalisation methods
Shell surface SI units were normalised using four diffe-
rent acquisition specific reference methods, based upon
established image analysis techniques [4–8]. Two of the
methods are direct ratios, indexing by a single acquisi-
tion specific metric: blood pool image intensity ratio
(BP-IIR- ratio of SI to blood pool mean) [4] and scar
image intensity ratio (Scar-IIR- ratio of SI to best scar in
reference slice) [5]. The other two methods index by
both a mean and a variance: nulled myocardium z-
score (V-Myo-Z: number of (ventricular myocardial)
standard deviations (SD) from healthy ventricular sep-
tal myocardium mean) [7], and blood pool z-score
(BP-Z: number of (blood pool) SDs from the blood
pool mean) [6, 8, 14]. For example, the threshold
used in this study (3.3 SDs above blood pool mean)
is the equivalent of thresholding the BP-Z normalised
shell at a value of + 3.3. Blood pool and scar refer-
ence values were obtained in a single standard slice
at the level of the aortic root. For blood pool values,
a 200mm2 circular ROI was placed in the LA blood
pool, distant from potential artefact due to inflow en-
hanced by respiratory navigator signal; for atrial scar
values, a 5mm2 ROI was placed within the most in-
tense region of PAAS within slice. Ventricular myo-
cardial mean and SD were obtained in the mid-
septum in a region (50mm2) of homogenous signal
intensity without blood pool contamination. Kurtosis
and skew are not controlled for in any of the index-
ing systems.
Table 1 Image acquisition and comparison nomenclature
3D Late Gadolinium Enhanced Acquisition Scan Session 1 Scan Session 2
10 min 20 min 30 min 10 min 20 min 30 min
Acq1 Acq2 Acq3 Acq4 Acq5 Acq6
Baseline Scan 20 min Acq0 C0,1 C0,2 C0,3 C0,4 C0,5 C0,6
Post ablation Scan 1 10 min Acq 1 – C1,2 C1,3 C1,4 C1,5 C1,6
20 min Acq 2 – – C2,3 C2,4 C2,5 C2,6
30 min Acq 3 – – – C3,4 C3,5 C3,6
Post-ablation Scan 2 10 min Acq 4 – – – – C4,5 C4,6
20 min Acq 5 – – – – – C5,6
30 min Acq 6 – – – – – –
Acqi is the i
th post-ablation LGE acquisition for each subject, Ci,j is the comparison between Acqi and Acqj
Second column is timing of commencement of acquisition, in minutes after administration of gadolinium based contrast agent
Fig. 2 Illustration of derivation of pulmonary vein encirclement (PVE) measurement. The left atrial shell is thresholded at 3.3 standard deviations above
the blood pool mean, with scar shown in red and healthy atrial myocardium in blue. a antero-superior view and b postero-lateral view of left atrium.
The computed route of the pulmonary vein (PV) encirclement is shown in yellow dashed line, whilst detected gaps in the ablation line are shown in
white. For this acquisition, the PV encirclement (PVE) for the right sided veins was 98.5%, and for the left was 81.5%. (LAA: left atrial appendage, LSPV:
left superior PV, LIPV: left inferior PV, RSPV: right superior PV, RIPV: right inferior PV)
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Shell comparisons
Following normalisation, intraclass correlation coeffi-
cients (ICCs) for both consistency and absolute agree-
ment were calculated on a face-by-face basis (typically
40,000 triangular faces per shell), exploiting the identical
morphology of the atrial shells.
Association of post-ablation atrial scar with arrhythmia
recurrence
Recurrence of AF post-ablation was defined as a recur-
rence of AF (>30s), or episodes of atrial tachycardia or
atrial flutter, in line with HRS/EHRA guidelines [19].
Follow-up was at 3 months post-ablation, with symptom
review, 24 h tape and 12-lead ECG performed. Subse-
quently, patients were typically reviewed at 6 and
12 months after the index procedure, and yearly there-
after. A 12-lead ECG ± holter monitor was performed at
each review, in the absence of reported symptoms. If
symptoms were reported, patients underwent 12-lead
ECG, Holter monitor or event monitor assessment,
according to symptom frequency. A blanking period of
three months was employed post ablation and the %LA
PAAS and %PVE were assessed against the binary out-
come of recurrence of atrial arrhythmia. Where a repeat
LA ablation procedure was performed, the presence or
absence of electrical reconnection of each PV pair was
recorded and corresponding PVE assessed.
Statistics
Normally distributed continuous variables are presented as
mean ± standard deviation, and median with interquartile
range (IQR) for non-normal distribution or non-continuous
ordinal data. Baseline characteristics and CMR indices were
compared using χ2 test or Student t-test as appropriate. Sta-
tistics were analysed using SPSS Statistics (Version 22, Inter-
national Business Machines, Armonk, New York, USA)
unless otherwise stated. For the comparison of scales with
intrinsic meaning and ratio scale, such as %LA PAAS or
PVE, and where identical imaging parameters were used
(‘Repro’ group), a within-subject coefficient of variation
(WCV) was calculated using a root mean square method
[20], otherwise an ICC was employed. ICC was calculated
using a two-way mixed effects model on the assumption
that the measurement technique (sequence timing, acquisi-
tion parameters and indexing technique) was a systematic
source of variance [21]. ICC was generated for both
consistency and absolute agreement using Matlab (Version
R2015a, The Mathworks, Inc. Natick, Massachusetts, USA),
and the ICC plugin (Arash Salarian, Version 1.2), C-1 and
A-1 type analysis for consistency and absolute agreement re-
spectively. Inter-scan ICC was calculated for C2,3,5,6 (four-
way comparison between Acq2,3,5,6). ICC of 0.41 to 0.60 was
interpreted to represent “moderate” agreement, 0.61 to 0.80
“good” agreement, and > 0.81 “excellent” agreement [22].
Repeated measures one-way ANOVA was used to assess dif-
ferences in ICC between normalisation methods, with
Tukey’s range test used to correct for multiple comparisons.
Results
The subject characteristics and acquisitions achieved are
summarised in Table 2, and there were no significant
differences between subjects that underwent Scan 2 in
1.5 T or 3 T scanner. There were a total of 231 out of
maximum possible 240 post-ablation acquisitions com-
pleted (96.2%). 40 acquisitions were completed at
10 min on scan 1 (Acq1), 40 Acq2, 37 Acq3, 39 Acq4, 39
Acq5 and 36 Acq6 (Fig. 1).
Reproducibility of thresholded PAAS imaging
Comparison of pre- and post-ablation atrial scar
When thresholded at the same value as PAAS (3.3 SD
above the blood pool mean), a very small proportion of
the LA shell was designated as baseline scar (median
0.62%, IQR 0.16–2.31%) (Fig. 3, bottom two panels).
There was a very weak overall correlation between the
proportion of pre-ablation scar and %LA PAAS (R2 =
0.024, p = 0.02 across all acquisitions). There was no sig-
nificant correlation on assessment of each imaging par-
ameter group (R2 for C0,1 to C0,6 ranged from 0.029 to
0.092, p-value 0.21 to 0.66). Overall average DSC, asses-
sing co-location of pre- and post-ablation scar, across all
acquisitions was very poor at 0.032 ± 0.009. Pre-ablation
scar location was therefore interpreted to be unrelated
to post ablation scar location and of minimal signifi-
cance in further assessment, and was not included in
further analysis.
Proportion of LA shell occupied by PAAS
%LA PAAS increased significantly with time from GBCA
for all acquisitions groups. Mean %LA PAAS at 10 min
(Acq1 and Acq4) was 7.1% ± 6.8%, increasing to 21.7 ±
15.6% at 20 min (Acq2 and Acq5) and 28.0 ± 16.1% at
30 min (Acq3 and Acq6) (p < 0.0001).
On interscan comparison of the acquisitions with
identical imaging parameters (‘Repro’), reproducibility
was poor at 10 min (C1,4- crosses in Fig. 4 top left panel)
but improved markedly at 20 min (C2,5: open circles)
and then 30 min (C3,6: closed circles). Reflecting this
improvement, WCV was poor at 10 min (0.76) but
improved significantly at 20 min (0.41) and again at
30 min (0.20) (p = 0.012).
Figure 4 also demonstrates Bland Altman plots where the
different imaging parameters were used in Scans 1 and 2.
Inter-scan ICCs (absolute agreement) generally improved
from 10 to 20 to 30 min for each subgroup: for ‘Half-slice’
they were 0.070, 0.267 and 0.496, ‘Half-Gad’ 0.342, 0.485
and 0.454, and ‘3 T’ 0.020, 0.737 and 0.825 respectively. For
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comparison, the ICCs for the ‘Repro’ group were 0.182,
0.678 and 0.723 respectively.
Given the poor scar detection and the very low repro-
ducibility at 10 min, Acq1 and Acq4 were excluded from
further analysis.
Pulmonary vein encirclement
PVE was significantly lower at 20 min than 30 min
(76.4 ± 21.9% versus 82.3 ± 18.1%, p < 0.001): mean
bias was − 5.9% (95% confidence interval − 29.8% to +
18.0%) (Fig. 5).
For inter-scan comparisons of the acquisitions with
identical imaging parameters (‘Repro’), the WCV was
0.126 at 20 min (C2,5[Repro]), improving to 0.045 at
30 min (C3,6[Repro], p = 0.02) (top left panel Fig. 6),
reflecting a high degree of reproducibility at both time
points.
When different parameters were used for the second
scan, the reproducibility remained acceptable. With a
half dose of GBCA, PVE was significantly higher at each
time point compared to standard imaging (standard:
70.7 ± 26.0% versus half gad: 84.7 ± 15.6%, p < 0.001), but
there was no significant inter-scan difference in PVE for
‘Half Slice’ or ‘3 T’ (p = 0.65 and 0.35 respectively) (Fig.
6). Inter-scan ICCs (absolute agreement) at 20 and
30 min for the ‘Half-gad’ group were 0.458 and 0.618,
for the ‘Half-slice’ group were 0.626 and 0.781 and for
the ‘3 T’ group were 0.697 and 0.809 respectively. For
comparison, the ICCs in the ‘Repro’ group were 0.774
and 0.876 respectively.
An analysis of additional determinants of PVE (%LA
PAAS and scan quality) is presented in the online
supplement.
Reproducibility of scar imaging without thresholding
The intra-and inter-scan ICCs for consistency and
agreement using all four normalisation methods are
shown in Table 3. Consistency reflects the trend for the
same regions in each acquisition to have higher norma-
lised signal intensities, whilst absolute agreement is a
more relevant measure of reproducibility if a fixed scar
threshold value is to be selected.
For the assessment of scans performed using the same
acquisition parameters (C2,3,5,6[Repro]), the consistency
and agreement was good for most normalisation
methods. However, of note the absolute agreement using
V-Myo Z-score was poor (0.436, IQR 0.339–0.549)),
reflecting poor absolute reproducibility of scar imaging
when this method is used to normalise SIs.
When different inter-scan imaging parameters were
used, the highest ICCs for absolute agreement were ob-
served with blood pool z-score normalisation (p = 0.038,
Tukey’s range test). With this normalisation method, the
inter-scan ICC (absolute agreement) remained as high as
0.670 (IQR 0.589–0.720), despite using the different
acquisition techniques.
Table 2 Baseline demographics, as assessed at the initial scan prior to ablation procedure
All Subjects (n = 40) Scan 2 1.5 T (n = 30) Scan 2 3 T (n = 10) p-value
Male 31 (78%) 22 (73%) 9 (90%) 0.27
Paroxysmal AF 20 (50%) 17 (56%) 3 (30%) 0.14
CHA2DS2VASC Score 1 (IQR 0–2) 1 (IQR 0–2) 0 (IQR 0–1.5) 0.28
AF duration (years) 3.0 (IQR 2.1–5.3) 2.5 (IQR 1.9–5.0) 5.5 (IQR 2.6–12.5) 0.19
Significant Comorbidities 22 (56%) 16 (53%) 6 (60%) 0.71
Age (years) 61 ± 10 61 ± 8 61 ± 13 0.99
Weight (kg) 88 ± 17 88 ± 18 87 ± 12 0.77
Height (cm) 176 ± 7.1 176 ± 6.4 177 ± 9.3 0.60
BMI (kg/m2) 28.4 ± 5.3 28.7 ± 5.9 27.6 ± 3.1 0.48
HR at baseline scan (bpm) 61 ± 10 61 ± 8 61 ± 13 0.99
Sinus rhythm at baseline scan 25 (62.5%) 19 (63%) 7 (70%) 0.70
LV ejection fraction (%) 60 ± 10 62 ± 10 58 ± 11 0.41
LA size (ml) 121 ± 32 122 ± 37 119 ± 19 0.75
LA fibrosis at baseline (%) 36.0 ± 13.9 36.7 ± 15.1 33.9 ± 9.3 0.49
LA ejection fraction (%) 30 ± 18 29 ± 19 34 ± 12 0.41
LV native T1 time (msec) 988 ± 22 991 ± 24 985 ± 21 0.33
P-value is for comparison between patients that underwent scan 2 in 1.5 T versus 3 T scanners. LA left atrium, LV left ventricle, BMI body mass index, HR heart
rate, bpm beats per minute. LA fibrosis was determined on manual segmentation of the left atrial wall, and thresholded at an image intensity ratio of 0.97 to the
blood pool mean- see Online Supplement for details [20]
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There was also high consistency and absolute agree-
ment between 20 min and 30 min acquisitions at the
same imaging session (intra-scan ICC 0.754–0.801
across all normalisation measures (C2,3 and C5,6)), except
when V-Myo Z-score was used where there was poor
absolute agreement (ICC 0.499, IQR 0.355–0.702)).
Recurrence of atrial arrhythmia
Follow-up time post ablation was for a median
417 days (IQR 285–628 days), and in total there were
13 patients (33%) with a recurrence of AF or
tachycardia. Eleven patients elected to undergo a fur-
ther ablation procedure, with two patients undergoing
conservative management (one with a single episode
of AF successfully treated with intravenous flecainide
at 566 days post ablation, and the second with a
single electrical cardioversion at 98 days, just outside
of the blanking period, both with no subsequent
recurrence).
Overall %LA PAAS was 23.3 ± 14.2% in the no recur-
rence group, and 28.3 ± 20.2% in the recurrence group
(p = 0.32). There was also no significant difference in
Fig. 3 Examples of raw images and corresponding scar shells for a single subject. Scans 1 and 2 were performed using identical (standard)
acquisition parameters, with acquisitions performed at 10 min, 20 min and 30 min post injection of gadolinium. Scan 2 was performed 2 days
after Scan 1. Upper six panels show single representative slices of the 3D late gadolinium enhancement (LGE) dataset, at the level of the aortic
root. The six panels below show corresponding scar shells, normalised according to blood pool z-score. Note the relatively poor reproducibility
for acquisitions at 10 min, particularly Scan 1. The bottom two panels show the baseline scan, performed 20 min after gadolinium based contrast
agent (GBCA) administration one month prior to ablation. Acq: acquisition. LSPV: left superior pulmonary vein, LIPV: left inferior pulmonary vein,
RSPV: right superior pulmonary vein, RIPV: right inferior pulmonary vein, LAA: left atrial appendage, SD: standard deviation
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average PVE between groups (no recurrence: 81.7%
(IQR 63.2–96.3%), recurrence: 86.1% (IQR 73.2–95.4%),
p = 0.10). Electrical reconnection of at least one PV pair
was confirmed in 10 of the 11 subjects that underwent
repeat ablation, and sites of reconnection versus respect-
ive PVE are shown in Fig. 7. There was no significant
relationship between PVE and likelihood of electrical
isolation of the vein pair: subjects could demonstrate
very high or even complete PVE on CMR imaging, but
still have electrical reconnection of the vein pair.
Complete PVE (> 99%) of both vein pairs was observed
in a total of 11 acquisitions (out of total 152 ‘late’
Fig. 4 Bland-Altman plots demonstrating the reproducibility of the proportion of the LA shell occupied by post ablation atrial scar (PAAS),
comparing scan acquisitions performed at the same time points post gadolinium administration. The top left chart shows the comparison for
acquisitions performed with identical imaging parameters (‘Repro’). The other three charts show the reproducibility for those performed with
differing imaging protocols, as previously detailed. Crosses show data points for comparison of acquisitions at 10 min post gadolinium (C1,4),
open circles for comparison of acquisitions at 20 min post gadolinium (C2,5), and closed circles for comparison of acquisitions at 30 min post
gadolinium (C3,6). Red lines show mean bias ±95% confidence interval
Fig. 5 Impact of time from GBCA administration upon pulmonary vein encirclement (PVE)
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acquisitions performed at 20 or 30 min post GBCA ad-
ministration, 7%). Of these, a recurrence was observed
on 3 occasions (27%, chi-square p = 0.94).
Discussion
The key findings of this study can be summarised as
follows:
1. There is good to excellent inter-scan reproducibility
of thresholded PAAS imaging when identical im-
aging parameters are used
2. There is good inter-scan reproducibility of non-
thresholded PAAS, provided that the signal inten-
sities are normalised using appropriate methods
3. Reproducibility of PAAS imaging is better for
acquisitions performed later (30 min) after GBCA
injection
4. Reproducibility of PAAS imaging is significantly
affected by the use of different imaging parameters,
particularly different doses of GBCA, but remains
acceptable when processed appropriately
5. There was no significant relationship between PAAS
summary indices and AF recurrence
Fig. 6 Reproducibility of pulmonary vein encirclement (PVE) measurements. Bland-Altman plots demonstrate reproducibility of measurements per-
formed at 20 min post GBCA (C2,5 (open squares)) and 30 min post GBCA (C3,6 (closed squares)). Red lines show mean bias ±95% confidence interval
Table 3 Intraclass correlation coefficients (ICCs) for point-by-point comparison, using each normalisation technique
Intra-scan
(C2,3 and C5,6)
Inter-scan
(C2,3,5,6)
Inter-scan
(‘Repro’ only)
Consistency Absolute
Agreement
Consistency Absolute
Agreement
Consistency Absolute
Agreement
Normalisation Method BP
Z-score
0.796
(IQR 0.729–0.848)
0.750
(IQR 0.667–0.827)
0.713
(IQR 0.659–0.764)
0.670
(IQR 0.589–0.720)
0.790
(IQR 0.767–0.799)
0.759
(IQR 0.739–0.768)
V-Myo
Z-score
0.754
(IQR 0.688–0.815)
0.499
(IQR 0.355–0.702)
0.677
(IQR 0.622–0.742)
0.363
(IQR 0.258–0.458)
0.748
(IQR 0.744–0.788)
0.436
(IQR 0.339–0.549)
BP IIR 0.788
(IQR 0.723–0.837)
0.743
(IQR 0.644–0.805)
0.691
(IQR 0.655–0.722)
0.628
(IQR 0.530–0.677)
0.770
(IQR 0.664–0.799)
0.679
(IQR 0.622–0.744)
Scar IIR 0.801
(IQR 0.752–0.852)
0.772
(IQR 0.647–0.813)
0.721
(IQR 0.682–0.774)
0.618
(IQR 0.491–0.694)
0.809
(IQR 0.773–0.828)
0.691
(IQR 0.576–0.744)
Values are median (with interquartile range (IQR)). IIR image intensity ratio, BP blood pool, V-Myo ventricular myocardium
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The reproducibility of the global summary indices of
thresholded PAAS (%LA PAAS and PVE) was good to ex-
cellent for identical imaging acquisition parameters (‘Re-
pro’), with WCV as good as 0.045 for imaging performed
at 30 min post-GBCA administration. Such a finding sug-
gests that the SD in PVE is less 5% of the PVE measure-
ment, a high degree of consistency in the imaging of a
structure as thin as the atrial wall, but the clinical implica-
tions of these small differences in measurements of PAAS
remain to be established. These measures of reproducibil-
ity are of a similar magnitude to those of ventricular vol-
ume and function parameters (coefficient of variation
(CV) 0.04–0.08 [23]) and ventricular scar imaging (CV
0.025–0.04 [24, 25]), both being widely accepted clinical
imaging modalities. The reproducibility in this study com-
pares favourably to that found for myocardial perfusion
imaging (CV between 0.16 and 0.35) [23].
When non-identical imaging parameters were used, an
ICC rather than WCV was used to assess for reproduci-
bility in view of the alteration of the baseline observa-
tional technique. The ICCs for PVE reproducibility at
30 min remained ‘good’ (0.61 to 0.81) for all parameter
alterations, and suggest that identical imaging parame-
ters are ideal but not essential for comparison of PAAS
imaging when imaging is processed appropriately. A
change in the GBCA had the greatest impact upon re-
producibility, with more PAAS detected, particularly at
earlier timepoints post-GBCA administration. However,
poor inter-scan reproducibility does not imply worse im-
aging with the altered parameter: reduced GBCA dose
may improve PAAS detection and warrants further in-
vestigation, in line with recent ventricular scar LGE im-
aging studies [26].
Imaging quality was found to be poorer when the 3D
LGE sequence was acquired at less than 20 min after
GBCA administration, and this was reflected in very low
markers of reproducibility for comparisons involving ac-
quisitions at 10 min post-GBCA administration. A
greater area of thresholded scar was consistently identi-
fied on scans acquired at 30 min than at 20 min. More-
over, on assessment of both %LA PAAS and PVE, the
measurements were significantly more reproducible at
30 min, perhaps reflecting the higher CNR observed at
this time point (Fig. 3) and the increased time for equili-
bration of contrast. PAAS identification, as opposed to
ventricular scar identification, is critically dependent
upon scar: blood pool contrast, rather than scar:healthy
myocardium contrast and this is likely to explain the
continued improvement in reproducibility at relatively
late time points [26, 27].
The use of a single threshold (3.3 standard deviations
above the blood pool mean) could have inappropriately
strengthened or weakened the measures of reproducibil-
ity, depending upon the clinical accuracy of the thresh-
old selected. It was therefore necessary also to employ a
measure of reproducibility that was independent of
thresholding, and the intra-scan and inter-scan reprodu-
cibility remained good. The ICC for inter-scan absolute
agreement was as high as 0.759 on a point-by-point ana-
lysis when only the reproducibility group was assessed.
This fell to 0.670 when all scanning parameter groups
were assessed, but this still represents moderate to good
reproducibility in the context of very different imaging
parameters and no thresholding. These ICCs are for ab-
solute agreement, which are important for comparison
between scans, enabling the designation of alternative
fixed thresholds. This study also suggests that it is valid
to compare scans between patients and scanning
sessions, even with different acquisition parameters,
provided that the imaging is normalised or thresholded
Fig. 7 Relationship between percentage PVE and electrical reconnection. Electrical reconnection was assessed at repeat procedure in patients who
had a sustained recurrence of arrhythmia (n = 11), and analysed as vein pairs (left and right, as indicated on charts). Closed circles indicate PVE at scan
1, open circles PVE at scan 2, and PVE scores are shown only for acquisitions at 20 min (Acq2 and Acq5) and 30 min (Acq3 and Acq6) post gadolinium
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appropriately. Normalisation should ideally be per-
formed using a blood pool Z-score, which was superior
to all other methods on assessment of ICC for absolute
agreement, but blood pool IIR and Scar IIR are only
marginally inferior. The V-Myo Z-score normalisation
demonstrated poor absolute ICC and should be avoided.
Association of PAAS imaging and outcome
The absence of a significant relationship in this study
between detection of gaps in the CMR-derived ablation
line and recurrence questions the immediate relevance of
PAAS imaging. This finding is in keeping with some re-
cent studies [6, 28], but at odds with others which have
demonstrated a significant relationship [5, 8, 10, 29].
However, it is important to review carefully those prior
publications with positive findings, as they themselves
have clearly delineated the limits of the relationship. For
example, in one of the earliest studies of PAAS in 2009,
Peters et al. found that the degree of scarring around only
the RIPV was significant in predicting recurrence, thought
to be likely to reflect the technical difficulty in isolating
that vein and propensity of triggers to arise from that loca-
tion [29]. Similarly, in 2010 Badger et al. found that only
10 out of 144 (7%) patients had complete scar encircle-
ment of all PVs, but that there were no recurrences in this
group, a statistically significant finding in a small subgroup
[10]. The metrics used to assess gaps in this study are ar-
guably more rigorous, but the overall proportion without
a gap in both vein pairs’ encirclement is similar (7% of ac-
quisitions had > 99% PVE of both veins), and in this case
was not associated with recurrence.
However, the interplay of interruption of the continuity
of the PVI lesion set and AF recurrence is a complex one:
many gaps will not necessarily lead to recurrence of
arrhythmia, whilst very small gaps may be sufficient for
electrical reconnection. [30–32]. Further work is clearly
required to fully understand the relationship between
electrical and imaging gaps in scar post-ablation, and the
impacts upon AF recurrence.
Clinical implications
PAAS imaging is currently used primarily as a research
tool, and enables the non-invasive evaluation of conven-
tional and novel ablation therapies, including assessment
of the impact of contact force [33], ablation-induced
modification of fat pads containing ganglionated plexi
[34], and also evaluation of ablation extent by cryobal-
loon [35]. The demonstration and quantification of the
reproducibility of the imaging technique will facilitate
the design and evaluation of further studies. Knowledge
of the inter-scan variability assists in the determination
of the sample size required to demonstrate a statistically
significant alteration in the parameter assessed. Further-
more, this study suggests that sample size could also be
reduced through ensuring that acquisitions are per-
formed later (20 to 30 min) post GBCA administration,
and, unsurprisingly, the use of identical imaging
parameters. However, this study also suggests that a
valid comparison of PAAS may be performed when it
has not been possible to ensure identical imaging para-
meters [3], albeit with wider confidence intervals and
the need for appropriate SI normalisation techniques.
The use of PAAS imaging to guide repeat ablation
procedures is more controversial. The results of this
study suggest that detection of PAAS is a reproducible
finding, but the clinical implications for guidance of
repeat procedures are unclear and warrant further
investigation.
Limitations
This study was performed at 3 months post ablation,
and is an evaluation of chronic scar formation. As such,
the results are not directly applicable to the assessment
of acute lesion formation, and could not be used to
guide acute repeat ablation during the index procedure
in a hybrid-type environment. Likewise, there is evidence
that there is a slow fading of scar with time [36], and the
application of these results to imaging > 3 months post-
ablation should be performed with caution.
There is also the possibility that the method of image
interrogation could introduce bias towards improved
reproducibility. The technique involved a rigid image
registration step, in order to maintain morphologically
identical LA shells which were important for subse-
quent assessments. The endocardial mask (GMRA ac-
quisition) was generally registered to the subsequent
LGE acquisitions (translation 1.9 ± 1.6 mm and rotation
0.62 ± 0.41°). For the majority of the subjects this was
performed blinded to scar, using the GMRA sequence
only. However, in five subjects the registration was of
a 10 min acquisition to subsequent LGE acquisitions.
The re-registration goodness of fit is evaluated across
all high contrast features within the dataset, including
bone and soft tissue, and therefore the effect of LA
scar (approx 6 ml within 6000 ml dataset, < 0.1%)
was felt to be negligible, particularly given the poor
PAAS enhancement on the 10 min acquisitions. A
further concern of the image processing technique,
using a maximum intensity projection, is that adjacent
bright structures such as the aorta may be interro-
gated. The processing technique, using an endocardial
mask based upon the high contrast GMRA, aimed to
minimise the contamination of signal from beyond
the atrial wall, but there remains the possibility that
reproducibility measures may have been increased by
mis-interrogation of static structures.
The summary indices of PAAS were all developed
specifically for this study and further validation of their
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robustness is warranted. In particular, the implementa-
tion of semi-automated steps in image interrogation has
meant that inter- and intra-observer variability has not
been explored in this study. Further evaluation of the
variation in summary indices warrants the re-
segmentation of the LA endocardium, with subsequent
image processing steps repeated. Finally, there is no gold
standard for assessment of accuracy of scar detection
and delineation. Manual segmentation was considered,
as has been performed in previous studies [11], but the
inter- and intraobserver variability was high for this sub-
jective measure. Core scar is clear to the expert observer,
but the borderzone of the scar depends upon a user de-
fined threshold and manual corroboration between
slices: it is these areas that are of particular importance
in the assessment of reproducibility but are inconsistent
on manual segmentation.
Conclusions
CMR imaging of PAAS is a reproducible finding when
the 3D LGE dataset is acquired at least 20 min after
the administration of GBCA. Inter-scan reproducibi-
lity is good to excellent when identical imaging pa-
rameters are used, and remains acceptable even when
acquisition parameters differ significantly. The clinical
implications of these findings remain to be established
in the absence of a simple relationship between PAAS
and AF recurrence.
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